Akebia Therapeutics
(AKBA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 149,800 | 207,204 | 246,992 | 252,765 | 228,698 |
| Receivables | 51,581 | 49,690 | 35,005 | 55,232 | 66,845 |
| Inventories | 36,628 | 33,688 | 37,898 | 44,806 | 61,017 |
| TOTAL | $271,149 | $330,084 | $331,076 | $365,017 | $371,437 |
| Non-Current Assets | |||||
| PPE Net | 6,754 | 7,196 | 7,670 | 8,168 | 8,622 |
| Intangibles | 167,171 | 172,191 | 181,201 | 190,212 | 199,223 |
| Other Non-Current Assets | 84,273 | 92,796 | 91,916 | 65,306 | 64,857 |
| TOTAL | $258,198 | $272,183 | $280,787 | $263,686 | $272,702 |
| Total Assets | $529,347 | $602,267 | $611,863 | $628,703 | $644,139 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 97,543 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 33,588 | 28,809 | 41,984 | 30,537 | 41,308 |
| Accrued Expenses | 109,014 | 144,704 | 111,742 | 123,889 | 130,624 |
| TOTAL | $261,051 | $189,205 | $165,595 | $172,679 | $187,146 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 97,230 | 96,917 | 96,607 | 96,378 |
| Deferred Revenues | 20,906 | 15,692 | 11,869 | 18,253 | 15,214 |
| Other Non-Current Liabilities | 172,814 | 150,717 | 158,122 | 126,227 | 87,652 |
| TOTAL | $194,288 | $275,912 | $271,637 | $242,133 | $209,375 |
| Total Liabilities | $455,339 | $465,117 | $437,232 | $414,812 | $396,521 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 181,231 | 174,960 | 174,538 | 160,115 | 153,502 |
| Common Shares | 1 | 2 | 2 | 2 | 1 |
| Retained earnings | -1,462,799 | -1,389,673 | -1,330,129 | -1,247,091 | -1,177,511 |
| Other shareholders' equity | 6 | 6 | 6 | 9 | 13 |
| TOTAL | $74,008 | $137,150 | $174,631 | $213,891 | $247,618 |
| Total Liabilities And Equity | $529,347 | $602,267 | $611,863 | $628,703 | $644,139 |